SUMMARY Forty-three subjects with uncomplicated primary hypertension and without echocardtographic left ventricular hypertrophy and 54 normotensive volunteers were studied by two-dimensional targeted M-mode echocardiography to evaluate systolic function and contractility before the development of compensatory hypertrophy. The ratio of peak systolic pressure to end-systolic dimension was used to assess left ventricular performance and was divided for either posterior wall thickness or cross-sectional area to generate hypertrophy-independent indices of inotropic state. Fractional shortening was normal in the hypertensive group, despite the increase in end-systolic stress. Systolic pressure/dimension ratio was higher in hypertensive subjects (p< 0.001), as were hypertrophy-independent indices of inotropic state (p< 0.005), which were inversely correlated to left ventricular mass (p<0.001). Values in 11 hypertensive subjects were above the upper confidence limit of the normal shortening/stress relation, which provides a load-independent measure of inotropic state. They showed high hypertrophy-independent indices of inotropic state (p<0.01), while the other hypertensive subjects did not. High fractional shortening, wall stress, and systolic pressure (p<0.01) were found in the subgroup with supernormal performance, while left ventricular mass was not different from that of other subgroups, depicting inadequate left ventricular hypertrophy. The duration of hypertension was the same in the subgroups. Supernormal inotropic state could be considered one form of primary adaptation to high wall stress that serves to maintain systolic ventricular performance. (Hypertension 11: 457-463, 1988) KEY WORDS • contractility • arterial hypertension • systolic function T HE role of left ventricular (LV) contractility in the maintenance of pump function during hypertensive disease is still under investigation. Some evidence suggests that performance is enhanced in subjects with primary hypertension, 1 " 3 but its mechanism of action is unclear. An increase in cardiac performance can be due to either improved inotropic state or an increase in the amount of myocardium available for contraction. Although enhancement of contractile force has been thought to be associated with increased LV mass,
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3 but its mechanism of action is unclear. An increase in cardiac performance can be due to either improved inotropic state or an increase in the amount of myocardium available for contraction. Although enhancement of contractile force has been thought to be associated with increased LV mass, 14 recently, Lutas et al. 3 showed that enhancement of cardiac performance was inde-pendent of the development of supercompensatory LV hypertrophy in hypertensive patients.
The findings concerning systolic function and its relationship to development of LV hypertrophy in hypertensive patients are often contradictory. In particular, the assessment of supernormal LV function in hypertensive patients seems to be inconsistent with the epidemiological evidence that one of the main adverse outcomes of hypertension is heart failure, especially in the presence of LV hypertrophy. 6 ' 7 How can this outcome be reconciled with findings of supernormal pump function? Are there two different kinds of hypertension, or does evolution from supernormal function to heart failure occur according to Meerson's hypothesis. 1 One possible bias in the studies on systolic function in hypertension could be the presence of hypertensive subjects with and without LV hypertrophy in the same population sample, with different degrees of wall stress and contractility and, therefore, with different patterns of LV function.
To evaluate inotropic state and its role in regulating 458 HYPERTENSION VOL 11, No 5, MAY 1988 systolic function in systemic hypertension and to avoid the possible bias represented by hypertrophied and nonhypertrophied left ventricles in the same population sample, we studied pump function in a group of hypertensive subjects without LV hypertrophy. To validate the employed index of LV performance, we verified its independence of load by intravenous infusion of sodium nitroprusside.
Subjects and Methods
Forty-three subjects (20 men and 23 women), aged 21 to 60 years (mean, 43.6 ± 8.9 years), with uncomplicated primary hypertension and 54 normotensive volunteers, matched for age, sex, and body surface area (Table 1) and without a family history of hypertensive diseases, entered this study. All participants were white, came from the district of Naples, and had the same dietary habits (as assessed by a questionnaire). None of them could be considered a habitual alcohol consumer, as only a little wine consumption was reported (from 0-3 glasses/day).
All hypertensive subjects were consecutive new patients at our hypertension clinic and were selected on the basis of their M-mode echocardiographic LV mass index, which was within 95% of the confidence interval of the normal controls (i.e., mean ± 2 SD). No hypertensive subject had ever received treatment for hypertension. Subjects in heart failure or with metabolic, endocrine, renal, or hepatic alterations were excluded from the study. Coronary artery disease was excluded by exercise testing on a bicycle; test results showed no alteration of ST segment. Abnormal regional septal thickening had been excluded previously by two-dimensional echocardiography. Diagnosis of primary hypertension was assessed as previously described. 8 Informed consent was obtained from all subjects.
Duration of hypertension was assessed on the basis of the first record of raised blood pressure (BP), which occurred between 6 and 18 months before the study (mean duration, 11 ±2.5 months). This information was considered reliable, because the hypertensive study subjects (9 air traffic controllers, 8 civil servants, 8 craftsmen, 8 physicians, 4 trade unionists, 2 schoolmasters, 2 farmers, and 2 policemen) underwent clinical checkups with some frequency. Because of the relatively recent detection of the disease, to exclude the possibility of borderline hypertension, stable hypertension was defined as diastolic BP (DBP) of 95 mm Hg or more on each of five measurements at the clinic on 5 different days.
All participants underwent a two-dimensional controlled M-mode echocardiogram between 0900 and 1000. A SIM3000 echocardiograph (OTE-Biomedica, Florence, Italy) with a 2.8-MHz transducer was employed; images were recorded on photographic paper at a velocity of 50 mm/sec. Echocardiograms were read in random sequence by two experienced physicians using standard conventions according to the indications of the American Society of Echocardiography. 9 A second reading was done at the zenith of the R wave of the reference electrocardiogram according to the Penn Convention for echocardiographic LV mass determination. 10 LV internal diameter at end-diastole (LVIDd) and at end-systole (LVTDs) were measured just below the tip of the mitral valve leaflets. Fractional shortening, defined as (LVIDd-LVIDs)/LVIDd X 100, was employed as an index of systolic function. LV weight was assessed by both LV mass 10 and meridional crosssectional area (CSA). 11 Relative diastolic wall thickness, defined as 2 x posterior wall thickness (PWT)/ LVIDd, was calculated as an index of concentric thickening of cardiac walls. End-systolic stress was calculated using the equation of Wilson et al. 12 ; echocardiogram and cuff blood pressure obtained with a random-zero sphygmomanometer (Hawksley, Lancing, UK) were assessed simultaneously as an index of afterload seen in the myocardium. LV mass and CSA were normalized for body surface area.
The ratio of peak systolic BP to LVIDs (SBP/ LVIDs) was considered indicative of overall LV performance. 4 ' 1J " 16 This ratio was normalized for PWT (SBP/LVIDs/PWT) to generate a hypertrophy-independent index of inotropic state." A further normalization was obtained by dividing SBP/LVIDs by CSA (SBP/UVTDs/CSA) to yield another index of inotropic state independent of hypertrophy. We tested the independence of load of SBP/LVEDs by obtaining regression lines at different loads in six hypertensive subjects by controlled infusion of sodium nitroprusside (5 mg/250 ml isotonic solution). Echocardiograms were performed at several steps between baseline and about 20% reduction of SBP. The variations of the SBP/ LVIDs ratio were compared with those of both the SBP to end-systolic volume ratio and the end-systolic stress to dimension ratio. The load independence of both SBP/LVIDs/PWT and SBP/LVIDs/CSA was also assessed.
All the data were expressed as mean values ± 1 SD, and the comparisons were performed by analysis of variance. Pearson's r coefficient was used to estimate the strength of relations. The Newman-Keuls test was used to examine the hemodynamic patterns of 11 hypertensive subjects showing fractional shortening greater than we could expect for their end-systolic stress.
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Results
Left Ventricular Hypertrophy
All indices of LV hypertrophy were enhanced in hypertensive subjects (Table 2) . LV mass and CSA snowed weak correlations with SBP and DBP (r = 0.32, p<0.05 for LV mass to SBP; r = 0.34, p<0.05 for LV mass to DBP; r = 0.38, p<0.0l for CSA to SBP; r = 0.39, p < 0.01 for CSA to DBP). 18 "
Left Ventricular Performance Table 3 shows that LV diastolic and systolic dimensions were normal in hypertensive subjects and, consequently, so was fractional shortening, despite the increase in wall stress. In both hypertensive and normotensive subjects, the inverse relation of fractional shortening to end-systolic stress was confirmed ( Figure I ).
2021
SBP/LVIDs was improved in hypertensive subjects and was correlated with fractional shortening (r = 0.79, p<0.001 for normotensive subjects; r = 0.66, p< 0.001 for hypertensive subjects) and relative wall thickness (r = 0.53, p<0.001 for normotensive subjects; r = 0.41, p<0.01 for hypertensive subjects). SBP/LVIDs/PWT and SBP/LVIDs/CSA were also higher in hypertensive subjects than in normal controls (see Table 3 ) and were directly correlated to fractional shortening (r = 0.66,p<0.001 in normotensive subjects and r = 0.59, p<0.001 in hypertensive subjects for SBP/LVIDs/PWT; r = 0.66, p<0.001 in normotensive subjects and r = 0.61, p<0.001 in hypertensive subjects for SBP/LVIDs/CSA) and inversely correlated to LV mass (r = -0.56, p<0.001 in normotensive subjects and r= -0.51, p< 0.001 in hypertensive subjects for SBP/LVIDs/PWT; r = -0.55, p<0.001 in normotensive subjects and r = -0.51, p<0.001 in hypertensive subjects for SBP/LVIDs/ CSA).
Evidence for a High Performance Subpopulation
As the index of LV performance was increased in hypertensive subjects, accounting for the finding of normal systolic function in the presence of high wall stress, we analyzed the distribution of hypertensive subjects in relation to the confidence interval of the normal relationship between fractional shortening and end-systolic stress. Figure 1 shows that values in 11 hypertensive subjects (26%) were above the upper confidence limit of the normal regression (i.e., 2 SD), indicating supernormal performance. Such a subpopulation was considered separately and compared with both the other subgroup of hypertensive subjects and the normotensive group. Table 4 shows that SBP/ LVIDs was increased in both subgroups, but more so in the supernormal performance subgroup than in the normal performance subgroup (p< 0.01). Conversely, hypertrophy-independent indices of inotropic state (SBP/LVIDs/PWT and SBP/LVIDs/CSA) were significantly enhanced only in the supernormal performance subgroup (p<0.01 vs normal controls). Of the hypertensive subjects with supernormal performance, SBP/LVTDs was greater than the normal mean ± 2 SD in six (54%) and SBP/LVIDs/PWT was greater in seven (64%). In the other subgroup (normal performance), nine hypertensive subjects (28%) had a high SBP/LVTDs and three (9%) had a high SBP/LVIDs/ PWT (Figure 2) . The different incidence of high SBP/LVIDs/PWT between the two subgroups was highly significant (p<0.0001). Several differences were observed between the two subpopulations, depicting two different hemodynamic patterns. As shown in Table 5 , no difference was found in age, body surface, and duration of the disease. SBP was higher in the subgroup with increased performance. DBP and heart rate were higher too, but the difference was not significant (see Table 5 ). No difference was found in cardiac dimensions. The slightly smaller LV end-systolic dimensions in subjects with supernormal performance explained their increased fractional shortening (p<0.05 vs normal controls and /?<0.01 vs the other subgroup; see Table 5 ).
End-systolic stress was higher in the supernormal 
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FIGURE 1. Correlation of fractional shortening to end-systolic stress in normotensive and hypertensive subjects. The dashed lines indicate 2 SDs above and below the regression lines in normotensive subjects.
performance subgroup than in the other hypertensive subgroup (see Table 5 ). This difference was due to either higher SBP values or inadequate thickness of cardiac walls. Despite the difference in BP values, no difference was found in LV mass index, in CSA index, in relative wall thickness, or in septal and parietal thickness between the subgroups ( Table 6 ). As compared with normal controls, both subpopulations showed a slight increase in LV weight that was significant for CSA index and the normal performance subgroup showed increased relative wall thickness and cardiac wall thickness (see Table 6 ).
Verification of the Independence of Load of SBP/LVIDs
To verify the actual independence of load of the employed index of LV performance, we compared it with another much used index of LV performance, SBP/end-systolic volume, and with three indices of inotropic state independent of hypertrophy, end-systolic stress/LVIDs, SBP/LVlDs/PWT, and SBP/ LVIDs/CSA, during controlled infusion of sodium nitroprusside. After infusion, which induced about a 20% reduction of SBP, end-systolic stress/LVIDs and SBP/end-systolic volume showed significant changes as compared with the baseline values, whereas no difference was found in SBP/LVIDs, SBP/LVLDs/PWT, and SBP/LVIDs/CSA (Table 7) .
Discussion
In accord with previous reports, 3 ' 5 in this study LV performance was improved in hypertensive subjects and this explained the finding of normal systolic function despite increased wall stress. Increased hypertrophy-independent indices of myocardial contractility indicated that, in our population sample, supernormal performance could be sustained by an improved inotropic state. Distribution of subjects according to the confidence limits of normal shortening/stress relation also confirmed the possibility of increased inotropism in a hypertensive subpopulation, because this relation provides a load-independent measure of inotropic state. In accord with observations by Lutas et al., 5 values in 11 patients (26% of the overall population sample) were above the upper confidence limit of the normal relation, indicating supernormal performance. The different distribution of the SBP/LVIDs/PWT ratio between the two hypertensive subgroups with normal and supernormal performance (see Figure 2) confirmed that improved inotropic state was involved in the finding of supernormal performance. Hypertensive subjects falling within the confidence interval of the normal shortening/stress relation also showed increased LV performance (SBP/LVIDs), probably because of an increase in the amount of myocardium available for contraction (hypertrophy-independent indices of inotropic state were not significantly different from normal). Although the main criterion of inclusion in this study was the exclusion of LV hypertrophy, in our population sample LV weight was higher than that 
FIGURE 2. Distribution of SBPileft ventricular internal systolic diameter (LVIDs) and SBP/LVIDs-posterior wall thickness (PWT) ratio values in normal controls and in hypertensive subpopulations with normal and supernormal performance. The dashed line indicates the normal mean; the solid lines indicate 2 SDs above and below the normal mean.
in normal controls and the coefficient of variation of LV mass index (0.18) was remarkably lower than that of prevous studies, 5 -19 revealing an upward shift in the distribution of the normal range. Furthermore, all the measures of hypertrophy were increased in this popu- 5 studying a population sample with a range of LV mass higher than that in our study, found that hypertensive subjects with a high performance did not have a LV mass index that was significantly different from normal. The possibility of an inverse relation between LV mass and inotropic state in arterial hypertension, suggested by others, 19 was also confirmed by the correlation we found Values are means ± SD. LVM and CSA were normalized for body surface area. LVM = left ventricular mass; CSA = cross-sectional area; RWT = relative diastolic wall thickness; ST = septal thickness; PWT = posterior wall thickness.
•p<0.01, t p < 0 . Values are means ± SD. LVIDs = left ventricular internal systolic diameter, ESV = end-systolic volume; ESS = end-systolic stress; PWT = posterior wall thickness; CSA = cross-sectional area.
•p<0.01, t p < 0.001, compared with baseline values.
between LV mass and hypertrophy-independent indices of inotropic state and had been suggested by the results of Takahashi et al.," reporting normal contractility in the lower degrees and contractile failure in the higher degrees of LV hypertrophy. In accord with several reports, 2 -'• "• M ' n our results suggest that systolic function in hypertensive subjects is sustained by improved inotropic state when LV hypertrophy is inadequate to reduce wall stress. When adequate LV hypertrophy occurs and wall stress decreases, inotropism can return to normal because LV pumping ability can be secured by the greater amount of myocardium available for contraction. This mechanism could be at work in the 32 hypertensive subjects who fell within the confidence interval of the normal shortening/stress relation. End-systolic stress was lower in this subgroup than in that with supernormal performance as a result of either lower SBP values or more adequate LV hypertrophy (relative wall thickness was significantly higher than that in normal subjects 5 ). In subjects with supernormal performance, the process of making LV hypertrophy compensatory to wall stress demand should take longer because of their higher BP values. When evaluated at rest, a direct, though invariably weak, correlation between LV weight and degree of hypertension is widely reported 18 ' "• ""^ and improves when blood pressure is measured during recurring stress. 24 On the basis of such relations, hypertensive subjects with supernormal performance should have shown LV mass higher than what could be expected for their BP values; these higher values would be justified by insufficient time elapsed for adequate LV hypertrophy to develop in this subgroup.
The sympathetic nervous system could play a key role in the evolution of the adequacy of LV hypertrophy by swiftly inducing an increase in the inotropic state (i.e., heart rate was increased, though insignificantly, in the high performance subgroup) and simultaneously stimulating the development of LV hypertrophy, 261 27 which is a slower process. Echocardiographic assessment of LV contractility is an application of the load-independent end-systolic relations of Sagawa et al. 13 a and its simplified derivation, peak pressure/end-systolic volume relation. 16 We tested the main indices of performance and inotropic state to verify their independence of load. During load manipulation by sodium nitroprusside, the SBP/ LVIDs ratio was steadier than were end-systolic volume and end-systolic stress SBP/LVIDs ratios, and its baseline value was considered indicative of LV performance. The SBP/LVIDs ratio was also examined as a value normalized for PWT and CSA because it does not incorporate the amount of myocardium available for contraction, which is an important variable conditioning development of LV force. Sodium nitroprusside infusion snowed the independence of load of both SBP/LVIDs/CSA and SBP/LVIDs/PWT. We considered the SBP/LVIDs ratio indicative of the contractile force developed by the whole left ventricle (LV performance) rather than of the inotropic state, which could be better indicated using the hypertrophy-corrected SBP/LVIDs ratio. The different incidence of high SBP/LVIDs/PWT in the hypertensive subgroups seems to confirm our assumption. We conclude that subjects with stable hypertension and without LV hypertrophy have better LV performance than do normal subjects. Analysis of the results reveals that two subgroups of hypertensive subjects could be identified in our population sample independently of age and duration of disease. The subgroup with increased performance also showed improved inotropic state. Such a pattern is associated with both highest wall stress and inadequate LV hypertrophy. The subgroup with normal performance showed a normal inotropic state, wall stress lower than that in other hypertensive subjects, and more adequate LV wall thickening. The time course, therapeutic implications, and prognostic importance of these two hemodynamic patterns should be further investigated.
